UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Artemisinin alleviates obesity‐related glomerulopathy by downregulating CYP24A1 expression

Diabetes, obesity & metabolism, 2024-02, Vol.26 (2), p.767-771

2024

Link zum Volltext

Verfügbarkeit prüfen

The Pathological Mechanisms of Obesity-Related Glomerulopathy: A review article

Iraqi journal of pharmaceutical sciences, 2021-06, Vol.30 (1), p.22-28

2021

Link zum Volltext

Verfügbarkeit prüfen

Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome

Chinese medical journal, 2018-11, Vol.131 (22), p.2713-2725

2018

Link zum Volltext

Verfügbarkeit prüfen

Collapsing focal segmental sclerosis in an HIV‐negative patient

Clinical case reports, 2020-11, Vol.8 (11), p.2166-2171

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between excess body weight and urine protein concentration in healthy dogs

Veterinary clinical pathology, 2014-06, Vol.43 (2), p.255-260

2014

Link zum Volltext

Verfügbarkeit prüfen

Childhood Obesity and the Metabolic Syndrome

The Pediatric clinics of North America, 2019-02, Vol.66 (1), p.31-43

2019

Link zum Volltext

Verfügbarkeit prüfen

Two children with obesity‐related glomerulopathy identified in a school urinary screening program

Pediatrics international, 2014-02, Vol.56 (1), p.115-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Determination of normal value of glomerular size in Chinese adults by different measurement methods

Nephrology (Carlton, Vic.), 2012-07, Vol.17 (5), p.488-492

2012

Link zum Volltext

Verfügbarkeit prüfen

Obesity—a neglected culprit in renal disease

Nephrology, dialysis, transplantation, 2002-07, Vol.17 (7), p.1157-1159

PRAGA, Manuel

2002

Link zum Volltext

Verfügbarkeit prüfen

Single-cell transcriptomic analysis reveals transcript enrichment in oxidative phosphorylation, fluid sheer stress, and inflammatory pathways in obesity-related glomerulopathy

Genes & diseases, 2024-07, Vol.11 (4), p.101101-101101, Article 101101

2024

Link zum Volltext

Verfügbarkeit prüfen

Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis

Phytomedicine (Stuttgart), 2023-07, Vol.116, p.154861-154861, Article 154861

2023

Link zum Volltext

Verfügbarkeit prüfen

High-calorie diet results in reversible obesity-related glomerulopathy in adult zebrafish regardless of dietary fat

American journal of physiology. Renal physiology, 2022-05, Vol.322 (5), p.F527-F539

2022

Link zum Volltext

Verfügbarkeit prüfen

The Renal Pathology of Obesity

Kidney international reports, 2017-03, Vol.2 (2), p.251-260

2017

Link zum Volltext

Verfügbarkeit prüfen

Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway

Obesity research & clinical practice, 2019-07, Vol.13 (4), p.385-390

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation

Life sciences (1973), 2018-04, Vol.198, p.112-118

2018

Link zum Volltext

Verfügbarkeit prüfen

Podocytopathy in Obesity: Challenges of Living Large

Seminars in nephrology, 2021-07, Vol.41 (4), p.307-317

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)

Journal of clinical & translational endocrinology, 2024-06, Vol.36, p.100341-100341, Article 100341

2024

Link zum Volltext

Verfügbarkeit prüfen

Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2

Life Sciences, 2020-10, Vol.258, p.118153-118153, Article 118153

2020

Link zum Volltext

Verfügbarkeit prüfen

Glomerular hyperfiltration: part 2—clinical significance in children

Pediatric nephrology (Berlin, West), 2023-08, Vol.38 (8), p.2529-2547

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care

Clinical kidney journal, 2023-04, Vol.16 (4), p.611-618

2023

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Obesity on Kidney Disease: Observational Cohort Study Analyzing 14,492 Kidney Biopsy Cases

Journal of Korean Medical Science, 2024, 39(3), , pp.1-11

2024

Link zum Volltext

Verfügbarkeit prüfen

Obesity-Related Glomerulopathy: Clinical Management

Seminars in nephrology, 2021-07, Vol.41 (4), p.358-370

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship between microalbuminuria, overweight and obesity

Journal of nephropathology, 2020-10, Vol.9 (4), p.e41-e41

2020

Link zum Volltext

Verfügbarkeit prüfen

Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes

American journal of physiology. Renal physiology, 2018-02, Vol.314 (2), p.F181-F189

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological Characteristics and Risk Factors for Rapid eGFR Decline in Chinese Patients with Biopsy-Proven Obesity-Related Glomerulopathy

Diabetes, metabolic syndrome and obesity, 2023, Vol.16, p.713-721

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Artemisinin alleviates obesity‐related glomerulopathy by downregulating CYP24A1 expression

The Pathological Mechanisms of Obesity-Related Glomerulopathy: A review article

Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome

Collapsing focal segmental sclerosis in an HIV‐negative patient

Association between excess body weight and urine protein concentration in healthy dogs

Childhood Obesity and the Metabolic Syndrome

Two children with obesity‐related glomerulopathy identified in a school urinary screening program

Determination of normal value of glomerular size in Chinese adults by different measurement methods

Obesity—a neglected culprit in renal disease

Single-cell transcriptomic analysis reveals transcript enrichment in oxidative phosphorylation, fluid sheer stress, and inflammatory pathways in obesity-related glomerulopathy

Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis

High-calorie diet results in reversible obesity-related glomerulopathy in adult zebrafish regardless of dietary fat

The Renal Pathology of Obesity

Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway

Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation

Podocytopathy in Obesity: Challenges of Living Large

Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)

Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2

Glomerular hyperfiltration: part 2—clinical significance in children

Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care

The Impact of Obesity on Kidney Disease: Observational Cohort Study Analyzing 14,492 Kidney Biopsy Cases

Obesity-Related Glomerulopathy: Clinical Management

The relationship between microalbuminuria, overweight and obesity

Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes

Clinicopathological Characteristics and Risk Factors for Rapid eGFR Decline in Chinese Patients with Biopsy-Proven Obesity-Related Glomerulopathy

Suchergebnisse filtern